Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00105664 · ClinicalTrials.gov registry record · NA
Collaborative Cardiac Care Project
A NA study of Coronary Disease and Myocardial Ischemia, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 287
- Enrollment target
- 4
- Study locations
NCT00105664: Completed NA study of Coronary Disease and Myocardial Ischemia, sponsored by US Department of Veterans Affairs.
NCT00105664 is a NA study of Coronary Disease and Myocardial Ischemia that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 287 participants, below the 2,011-participant average among 34 other Coronary Disease trials with a reported enrollment target (86% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00105664, a NA study of Coronary Disease and Myocardial Ischemia, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 287 participants
- Enrollment target
- 4
- Study locations
Study Summary
Data from VA-funded studies and the broader literature indicate that chronic stable angina (CSA) is prevalent, under recognized, under treated and associated with reduced quality of life. There are substantial opportunities for improving care of patients with this debilitating and potentially fatal problem. Because primary care providers manage most patients with CSA, efforts to improve care must necessarily involve the primary care delivery system. C3P is composed of a set of interventions employing a Collaborative Care Team model, which has been shown to be effective in managing other chronic illnesses in the primary care setting.
Conditions Studied
Interventions
- PROCEDURE Collaborative care model
- PROCEDURE Group interventions
- PROCEDURE Facilitated consultation
Study Locations (4)
California
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Colorado
- VA Eastern Colorado Health Care System, Denver, CO - Denver
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 287 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-07 |
| Phase | NA |
What the finished NCT00105664 record still lists
NCT00105664 is an interventional study that assigns participants to a tested intervention. The registered 287 participants enrollment target is mid-sized for trials with a published cap, below the 2,011-participant average among 34 other Coronary Disease trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Coronary Disease appearing as the primary indexed condition, and to 3 interventions - of which Collaborative care model is the first listed.
NCT00105664 reports a single indexed study location in California, Colorado, Oregon.
Frequently Asked Questions
What is clinical trial NCT00105664 about?
NCT00105664 is a clinical study titled "Collaborative Cardiac Care Project". Data from VA-funded studies and the broader literature indicate that chronic stable angina (CSA) is prevalent, under recognized, under treated and associated with reduced quality of life. There are substantial opportunities for improving care of patients with this debilitating and potentially fatal ...
What is the current status of trial NCT00105664?
This trial is currently completed. It is a NA study. The enrollment target is 287 participants. The study started on 2004-10. Estimated completion is 2007-07.
What conditions does trial NCT00105664 study?
This clinical trial studies the following conditions: Coronary Disease, Myocardial Ischemia, Angina Pectoris.
What interventions are being tested in trial NCT00105664?
The interventions under investigation include: Collaborative care model (PROCEDURE), Group interventions (PROCEDURE), Facilitated consultation (PROCEDURE).
Who is sponsoring clinical trial NCT00105664?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00105664 being conducted?
This trial has 4 study locations across California, Colorado, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00105664's enrollment target sits among peer trials
287 21st of 34 higher than 14 of 34 other Coronary Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating New Radiation Techniques for Cardiovascular Imaging
RECRUITING · NA
-
Sapphire 3 CTO Study
COMPLETED · NA
-
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
COMPLETED · NA
-
Effects of Training Intensity on the CHD Risk Factors in Postmenopausal Women
COMPLETED · NA
-
Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions
COMPLETED · NA
-
Time Restricted Feeding for Weight Loss and Cardio-protection
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03094429 · 287 participants · Phase 2
An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- NCT06385080 · 287 participants · Phase 1
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
- NCT06919224 · 287 participants · NA
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
- NCT02098265 · 288 participants · NA
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia